Literature DB >> 15994789

Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.

Sanjeev Choudhary1, Steve Boldogh, Roberto Garofalo, Mohammad Jamaluddin, Allan R Brasier.   

Abstract

A member of the Paramyxoviridae family of RNA viruses, respiratory syncytial virus (RSV), is a leading cause of epidemic respiratory tract infection in children. In children, RSV primarily replicates in the airway mucosa, a process that alters epithelial cell chemokine expression, thereby inducing airway inflammation. We investigated the role of the mitogen-activated protein kinase kinase kinase 14/NF-kappaB-inducing kinase (NIK) in the activation of NF-kappaB-dependent genes in alveolus-like A549 cells. RSV infection induces a time dependent increase of NIK mRNA and protein expression that peaks 12 to 24 h after viral exposure. Immunoprecipitation kinase assays indicate that NIK kinase activity is activated even more rapidly (within 6 h of RSV adsorption) associated with an endogenous approximately 50-kDa NF-kappaB2 substrate. Because NIK associates with IKKalpha to mediate processing of the 100-kDa NF-kappaB2 precursor into its 52-kDa DNA binding isoform ("p52"), the effects of RSV on NIK complex formation with IKKalpha and NF-kappaB2 were determined by coimmunoprecipitation assay. We find that NIK, IKKalpha, and both 100 kDa- and 52-kDa NF-kappaB2 isoforms strongly complex 15 h after exposure to RSV at times subsequent to NIK kinase activation. Western immunoblot and microaffinity DNA pull-down assays showed a parallel increase in nuclear translocation and DNA binding of the NF-kappaB2-Rel B complex. Interestingly, we make the novel observations that NIK also transiently translocates into the nucleus complexed with 52-kDa NF-kappaB2. Small interfering RNA-mediated NIK "knock-down" blocked RSV-inducible 52-kDa NF-kappaB2 processing and interfered with the early activation of a subset of NF-kappaB-dependent genes, indicating the importance of this activation pathway in the genomic NF-kappaB response to RSV. Together, these data indicate that RSV infection rapidly activates the noncanonical NF-kappaB activation pathway prior to the more potent canonical pathway activation. This appears to be through a novel mechanism involving induction of NIK kinase activity, expression, and nuclear translocation of a ternary complex with IKKalpha and processed NF-kappaB2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994789      PMCID: PMC1168720          DOI: 10.1128/JVI.79.14.8948-8959.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 2.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

Review 3.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

Review 4.  Structure, regulation and function of NF-kappa B.

Authors:  U Siebenlist; G Franzoso; K Brown
Journal:  Annu Rev Cell Biol       Date:  1994

5.  Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin-6.

Authors:  C T Sherman; A R Brasier
Journal:  Mol Endocrinol       Date:  2001-03

6.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

7.  Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line.

Authors:  T L Noah; S Becker
Journal:  Am J Physiol       Date:  1993-11

8.  Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells.

Authors:  M Jamaluddin; R Garofalo; P L Ogra; A R Brasier
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells.

Authors:  M A Fiedler; K Wernke-Dollries; J M Stark
Journal:  Am J Physiol       Date:  1995-12

10.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Authors:  K L Guan; J E Dixon
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

View more
  37 in total

1.  Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.

Authors:  Michael E Speer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

2.  TAK1 regulates NF-ΚB and AP-1 activation in airway epithelial cells following RSV infection.

Authors:  Nilay Dey; Tianshuang Liu; Roberto P Garofalo; Antonella Casola
Journal:  Virology       Date:  2011-08-10       Impact factor: 3.616

3.  Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity.

Authors:  Jin Jin; Hongbo Hu; Haiyan S Li; Jiayi Yu; Yichuan Xiao; George C Brittain; Qiang Zou; Xuhong Cheng; Frédérick A Mallette; Stephanie S Watowich; Shao-Cong Sun
Journal:  Immunity       Date:  2014-03-20       Impact factor: 31.745

4.  Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.

Authors:  Mohammad Jamaluddin; Sanjeev Choudhary; Shaofei Wang; Antonella Casola; Ruksana Huda; Roberto P Garofalo; Sutapa Ray; Allan R Brasier
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  High throughput short interfering RNA (siRNA) screening of the human kinome identifies novel kinases controlling the canonical nuclear factor-κB (NF-κB) activation pathway.

Authors:  Sanjeev Choudhary; Kevin P Rosenblatt; Ling Fang; Bing Tian; Zhao-Hui Wu; Allan R Brasier
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

6.  Quantitation of the dynamic profiles of the innate immune response using multiplex selected reaction monitoring-mass spectrometry.

Authors:  Yingxin Zhao; Bing Tian; Chukwudi B Edeh; Allan R Brasier
Journal:  Mol Cell Proteomics       Date:  2013-02-15       Impact factor: 5.911

7.  Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65.

Authors:  Anika Hävemeier; Silvia Gramolelli; Marcel Pietrek; Ramona Jochmann; Michael Stürzl; Thomas F Schulz
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

8.  Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.

Authors:  Srikanth Kota; Ahmed Sabbah; Te Hung Chang; Rosalinda Harnack; Yan Xiang; Xiangzhi Meng; Santanu Bose
Journal:  J Biol Chem       Date:  2008-06-20       Impact factor: 5.157

9.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.

Authors:  Diane C Munday; Edward Emmott; Rebecca Surtees; Charles-Hugues Lardeau; Weining Wu; W Paul Duprex; Brian K Dove; John N Barr; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-07-20       Impact factor: 5.911

Review 10.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.